rdf:type |
|
lifeskim:mentions |
umls-concept:C0008625,
umls-concept:C0010453,
umls-concept:C0015915,
umls-concept:C0025186,
umls-concept:C0038323,
umls-concept:C0086418,
umls-concept:C0150312,
umls-concept:C0390817,
umls-concept:C1441547,
umls-concept:C1511572,
umls-concept:C1521828
|
pubmed:issue |
9
|
pubmed:dateCreated |
2004-8-23
|
pubmed:abstractText |
The objective of the study was to investigate the effect of Follicular-Fluid Meiosis Activating Sterol (FF-MAS) when added to the culture media on the incidence of chromosomal abnormalities and pre-embryo development in human pre-embryos.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0268-1161
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
19
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2109-17
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15243006-Adult,
pubmed-meshheading:15243006-Blastocyst,
pubmed-meshheading:15243006-Blastomeres,
pubmed-meshheading:15243006-Cells, Cultured,
pubmed-meshheading:15243006-Cholestenes,
pubmed-meshheading:15243006-Chromosome Aberrations,
pubmed-meshheading:15243006-Cleavage Stage, Ovum,
pubmed-meshheading:15243006-Cytogenetic Analysis,
pubmed-meshheading:15243006-Cytoplasm,
pubmed-meshheading:15243006-Dose-Response Relationship, Drug,
pubmed-meshheading:15243006-Double-Blind Method,
pubmed-meshheading:15243006-Embryonic Development,
pubmed-meshheading:15243006-Female,
pubmed-meshheading:15243006-Fertilization,
pubmed-meshheading:15243006-Fertilization in Vitro,
pubmed-meshheading:15243006-Follicular Fluid,
pubmed-meshheading:15243006-Humans,
pubmed-meshheading:15243006-Metaphase,
pubmed-meshheading:15243006-Mosaicism,
pubmed-meshheading:15243006-Oocytes,
pubmed-meshheading:15243006-Osmolar Concentration
|
pubmed:year |
2004
|
pubmed:articleTitle |
Chromosomal abnormality rate in human pre-embryos derived from in vitro fertilization cycles cultured in the presence of Follicular-Fluid Meiosis Activating Sterol (FF-MAS).
|
pubmed:affiliation |
Reproductive Medicine, Department of Obstetrics and Gynecology, Sahlgrenska University Hospital, Göteborg, Sweden. christina.bergh@vgregion.se
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase I
|